Hi @steplightly have recently covered all bases with emails re Prolia - happy to provide my original email and the responses from the distributor Amgen , the Office of the Federal Minister for health and others . Essentially the Federal gov has complex admin processes in play for a drug to be registered on PBS. The distributor is motivated by profit and the number of women who might use Prolia due to bc treatment may not be large enough. On top of this is Federal budget deficit considerations of which the Health budget is a major player.
I applaud your courageous decision however to speak up about matters that concern you - it is the only way change ultimately occurs however be aware it may be a long slog and requires many voices.
